Efficacy and Safety of Zoledronic Acid in Patients With Bone Metastases of Any Solid Tumors or Multiple Myeloma
Clinical trial NCT00219258 · COMPLETED
Trial details
- NCT number
- NCT00219258
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.